TD Capital Management’s Pfizer PFE Stock Holding History

TD Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30K	Buy	1,069 +7	+0.7%	+$186	﹤0.01%	306
2025 Q4	$26.5K	Buy	1,062 +6	+0.6%	+$151	﹤0.01%	313
2025 Q3	$26.9K	Sell	1,056 -18	-2%	-$444	﹤0.01%	286
2025 Q2	$26K	Buy	1,074 +304	+39%	+$7.09K	﹤0.01%	284
2025 Q1	$19.5K	Buy	770 +3	+0.4%	+$79	﹤0.01%	255
2024 Q4	$20.4K	Sell	767 -487	-39%	-$13.2K	﹤0.01%	240
2024 Q3	$36.3K	Buy	1,254 +215	+21%	+$6.27K	﹤0.01%	210
2024 Q2	$29.1K	Buy	1,039 +2	+0.2%	+$55	﹤0.01%	219
2024 Q1	$28.8K	Buy	1,037 +50	+5%	+$1.39K	﹤0.01%	219
2023 Q4	$28.4K	Sell	987 -727	-42%	-$22K	﹤0.01%	223
2023 Q3	$56.9K	Buy	1,714 +10	+0.6%	+$354	0.01%	163
2023 Q2	$62.5K	Buy	1,704 +9	+0.5%	+$350	0.01%	159
2023 Q1	$69.2K	Buy	1,695 +9	+0.5%	+$389	0.01%	150
2022 Q4	$86.4K	Buy	1,686 +6	+0.4%	+$288	0.01%	129
2022 Q3	$74K	Buy	+1,680	New	+$81.6K	0.01%	132
2022 Q1	–	Sell	-2,020	Closed	-$119K	–	273
2021 Q4	$119K	Sell	2,020 -171	-8%	-$8.47K	0.01%	115
2021 Q3	$94K	Buy	2,191 +8	+0.4%	+$354	0.01%	122
2021 Q2	$85K	Buy	2,183 +234	+12%	+$9.1K	0.01%	118
2021 Q1	$71K	Buy	1,949 +660	+51%	+$23.4K	0.01%	120
2020 Q4	$47K	Buy	1,289 +405	+46%	+$14.9K	0.01%	130
2020 Q3	$31K	Hold	884	–	–	﹤0.01%	136
2020 Q2	$27K	Hold	884	–	–	﹤0.01%	135
2020 Q1	$27K	Sell	884 -186	-17%	-$6.34K	0.01%	127
2019 Q4	$40K	Sell	1,070 -59	-5%	-$2.1K	0.01%	128
2019 Q3	$38K	Sell	1,129 -1,004	-47%	-$36.5K	0.01%	126
2019 Q2	$88K	Buy	2,133 +1,263	+145%	+$50.2K	0.02%	70
2019 Q1	$35K	Hold	870	–	–	0.01%	94
2018 Q4	$36K	Buy	870 +53	+6%	+$2.2K	0.01%	92
2018 Q3	$34K	Buy	817 +429	+111%	+$16.5K	0.01%	94
2018 Q2	$13K	Hold	388	–	–	﹤0.01%	123
2018 Q1	$13K	Hold	388	–	–	﹤0.01%	126
2017 Q4	$13K	Hold	388	–	–	﹤0.01%	121
2017 Q3	$13K	Buy	388 +192	+98%	+$6.17K	﹤0.01%	121
2017 Q2	$6K	Hold	196	–	–	﹤0.01%	136
2017 Q1	$6K	Hold	196	–	–	﹤0.01%	136
2016 Q4	$6K	Hold	196	–	–	﹤0.01%	134
2016 Q3	$6K	Sell	196 -52	-21%	-$1.74K	﹤0.01%	121
2016 Q2	$8K	Hold	248	–	–	﹤0.01%	112
2016 Q1	$7K	Hold	248	–	–	﹤0.01%	114
2015 Q4	$8K	Hold	248	–	–	﹤0.01%	113
2015 Q3	$7K	Hold	248	–	–	﹤0.01%	119
2015 Q2	$8K	Buy	248 +52	+27%	+$1.7K	﹤0.01%	123
2015 Q1	$6K	Hold	196	–	–	﹤0.01%	129
2014 Q4	$6K	Buy	196 +1	+0.5%	+$29	﹤0.01%	134
2014 Q3	$5K	Buy	195 +2	+1%	+$56	﹤0.01%	133
2014 Q2	$5K	Buy	193 +2	+1%	+$57	﹤0.01%	139
2014 Q1	$6K	Buy	191 +1	+0.5%	+$30	﹤0.01%	136
2013 Q4	$6K	Sell	190 -3,786	-95%	-$110K	﹤0.01%	138
2013 Q3	$108K	Sell	3,976 -491	-11%	-$13.4K	0.03%	88
2013 Q2	$119K	Buy	+4,467	New	+$123K	0.03%	65

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

TD Capital Management's PFE Position: Q1 2026 in Review

TD Capital Management increased its Pfizer (PFE) stake by 0.66% in Q1 2026, buying an estimated $186 and bringing the position to 1,069 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

TD Capital Management first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $119K in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

TD Capital Management held 1,069 shares of Pfizer worth $30K as of Q1 2026.
TD Capital Management bought 7 Pfizer shares in Q1 2026, an estimated $186.
Pfizer made up ﹤0.01% of TD Capital Management's portfolio in Q1 2026, its #306 holding.
TD Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
TD Capital Management's Pfizer position peaked at $119K in Q4 2021.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.